ArticleGeneral thoracic and cardiovascular surgery cases2023

Achievement of pathological complete response with osimertinib for EGFR-mutated lung adenocarcinoma.

Yasuhiro Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.